Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.39 |
| ▸ | CTSA | P10619 | 2/20 | 0.35 |
| ▸ | PKM | P14618 | 1/20 | 0.34 |
| ▸ | FNTA | P49354 | 1/20 | 0.34 |
| ▸ | FNTB | P49356 | 1/20 | 0.34 |
| ▸ | EGLN2 | Q96KS0 | 1/20 | 0.33 |
| ▸ | SCN9A | Q15858 | 5/20 | 0.33 |
| ▸ | S1PR4 | O95977 | 1/20 | 0.32 |
| ▸ | S1PR1 | P21453 | 1/20 | 0.32 |
| ▸ | S1PR3 | Q99500 | 1/20 | 0.32 |
| ▸ | CYP11B1 | P15538 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28754410 | 0.86 | EGLN2 (0.37) | CTSAPKMEGLN2SCN9A | |
| SCHEMBL22391829 | 0.84 | PKM (0.34) | CTSAPKMFNTAFNTBEGLN2 | |
| SCHEMBL29170101 | 0.84 | L3MBTL1 (0.39) | L3MBTL1SCN9A | |
| SCHEMBL29159983 | 0.83 | FNTA (0.32) | CTSAFNTAFNTBS1PR4S1PR1 | |
| SCHEMBL29170087 | 0.82 | L3MBTL1 (0.37) | L3MBTL1SCN9A | |
| SCHEMBL10630728 | 0.82 | CES2 (0.39) | L3MBTL1CTSA | |
| SCHEMBL29170089 | 0.81 | L3MBTL1 (0.36) | L3MBTL1SCN9A | |
| SCHEMBL29170142 | 0.81 | L3MBTL1 (0.36) | L3MBTL1SCN9ACYP11B1 | |
| SCHEMBL28754383 | 0.81 | EGLN2 (0.35) | CTSAPKMEGLN2S1PR4S1PR1 | |
| Hydrochloric Acid SCHEMBL28944814 | 0.76 | IKBKB (0.36) | CYP11B1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-113227068-B | GLP-1R agonists and uses thereof | 上海齐鲁锐格医药研发有限公司 | 2023-06-13 | — | — | CN | disclosed |
| CN-113831337-B | GLP-1 receptor agonist, and pharmaceutical composition and use thereof | 广州市恒诺康医药科技有限公司 | 2023-03-24 | — | — | CN | disclosed |
| CN-113831337-A | GLP-1 receptor agonist, and pharmaceutical composition and use thereof | 广州市恒诺康医药科技有限公司 | 2021-12-24 | — | — | CN | disclosed |